KarXT for schizophrenia in Chinese adults
Treatments studied
Part of Mental health clinical trials.
This study is testing the safety and effectiveness of a new medication called KarXT for adults with schizophrenia. Participants will take the medication as part of their regular care, and researchers will track how well it works and any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have a diagnosis of schizophrenia.
- You must be willing to take the study medication (KarXT) alone, without other antipsychotics.
- Your schizophrenia must not be 'treatment-resistant' – meaning you haven't already tried two or more different antipsychotics without improvement.
- You cannot have serious health problems like severe liver/kidney disease, bladder blockage, or narrow-angle glaucoma.
- You cannot be pregnant, planning pregnancy, or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how well KarXT works and what side effects it might have when people with schizophrenia switch to it from their current antipsychotic medication. It may be an option for those who have started KarXT recently or who plan to switch from their current treatment.
This study tests a new medicine (KarXT) for schizophrenia, focusing on how it affects urological (bladder and urinary) safety. You'll stop your current antipsychotic and take the study drug to see if it works well and is safe for your urinary system.
This trial tests a new medication called KarXT for people with schizophrenia who are currently having a psychotic episode. It is for Japanese adults who have had schizophrenia before and are not in their first episode.
This trial tests if a new medicine, KarXT, can safely and effectively treat schizophrenia in adolescents. It may help teenagers who have active symptoms like hallucinations or disorganized thinking.
This trial tests a new injectable form of KarXT for schizophrenia. It aims to see if the medicine is safe, tolerable, and how it works in the body.
This trial tests whether a new oral medication, KarXT, can help prevent a return of schizophrenia symptoms in people who have been stable on treatment. If you've had a hospital stay in the past year and still have some symptoms, you may be able to join.
Hear when a new Schizophrenia Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.